Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if vitamin E can help treat prostate cancer. Vitamin
E acts primarily as an anti-oxidant. By decreasing the oxidation in the cancer cell, the
tumor cells may die. Vitamin E is a commonly used vitamin that has not been approved by the
Food and Drug Administration for use in this type of cancer or for any known cancer. This
study will test the hypothesis that vitamin E, in the setting of an oxidative stress such as
smoking, can reduce prostate cancer related biomarkers in patients with localized prostate
cancer in the neoadjuvant setting.
Phase:
Phase 3
Details
Lead Sponsor:
New Mexico Cancer Care Alliance
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins